These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35382673)

  • 1. Impact of infectious diseases consultation among patients with infections caused by gram-negative rod bacteria: a systematic literature review and meta-analysis.
    Hasegawa S; Kakiuchi S; Tholany J; Kobayashi T; Marra AR; Schweizer ML; Samuelson RJ; Suzuki H
    Infect Dis (Lond); 2022 Aug; 54(8):618-621. PubMed ID: 35382673
    [No Abstract]   [Full Text] [Related]  

  • 2. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).
    Paul M; Carrara E; Retamar P; Tängdén T; Bitterman R; Bonomo RA; de Waele J; Daikos GL; Akova M; Harbarth S; Pulcini C; Garnacho-Montero J; Seme K; Tumbarello M; Lindemann PC; Gandra S; Yu Y; Bassetti M; Mouton JW; Tacconelli E; Rodríguez-Baño J
    Clin Microbiol Infect; 2022 Apr; 28(4):521-547. PubMed ID: 34923128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis.
    Falagas ME; Tansarli GS; Rafailidis PI; Kapaskelis A; Vardakas KZ
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4214-22. PubMed ID: 22615292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia.
    Shulder S; Tamma PD; Fiawoo S; Dzintars K; Escobar D; Livorsi DJ; Malani AN; Palacio D; Spivak ES; Zimmerman M; Bork JT
    Clin Infect Dis; 2023 Nov; 77(9):1234-1237. PubMed ID: 37402637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality.
    Horikoshi Y; Suwa J; Higuchi H; Kaneko T; Furuichi M; Aizawa Y; Fukuoka K; Okazaki K; Ito K; Shoji T
    Int J Infect Dis; 2017 Nov; 64():69-73. PubMed ID: 28941633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic.
    Oliva A; Giacobbe DR; Di Luca M; Miller NS
    Biomed Res Int; 2018; 2018():8905874. PubMed ID: 30671476
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-abdominal infections: do we need to change our antibiotic coverage in this era of Gram negative resistance?
    Gopalakrishnan R
    J Assoc Physicians India; 2011 May; 59():285. PubMed ID: 21751603
    [No Abstract]   [Full Text] [Related]  

  • 8. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
    Chopra I; Schofield C; Everett M; O'Neill A; Miller K; Wilcox M; Frère JM; Dawson M; Czaplewski L; Urleb U; Courvalin P
    Lancet Infect Dis; 2008 Feb; 8(2):133-9. PubMed ID: 18222164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria.
    Teng CB; Koh PT; Lye DC; Ang BS
    Int J Antimicrob Agents; 2008 Jan; 31(1):80-2. PubMed ID: 17920246
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of polymyxin resistance in Gram-negative bacteria.
    Olaitan AO; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):581-582. PubMed ID: 27939183
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospital-acquired infections due to gram-negative bacteria.
    Peleg AY; Hooper DC
    N Engl J Med; 2010 May; 362(19):1804-13. PubMed ID: 20463340
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination antimicrobial therapy for extensively-drug resistant gram-negative bacteria: great help or superfluity].
    She DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jul; 42(7):495-499. PubMed ID: 31365964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.
    O'Neill AJ
    Expert Opin Investig Drugs; 2008 Mar; 17(3):297-302. PubMed ID: 18321229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-adherence to infectious disease consultations: are surgeons to blame?
    Madariaga MG
    J Antimicrob Chemother; 2006 May; 57(5):1019-20. PubMed ID: 16531432
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
    Boyd N; Nailor MD
    Pharmacotherapy; 2011 Nov; 31(11):1073-84. PubMed ID: 22026395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, control and treatment of multiresistant gram-negative rods.
    Wiedemann B
    Drugs; 1996; 52 Suppl 2():95-100; discussion 100-2. PubMed ID: 8869845
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistant gram-negative infections.
    Fraimow H; Nahra R
    Crit Care Clin; 2013 Oct; 29(4):895-921. PubMed ID: 24094384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.
    Savoldi A; Carrara E; Piddock LJV; Franceschi F; Ellis S; Chiamenti M; Bragantini D; Righi E; Tacconelli E
    BMC Infect Dis; 2021 Jun; 21(1):545. PubMed ID: 34107899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.